Development	O
and	O
validation	B:C1519941
of	O
the	O
self	O
-	I:C0681906
reported	I:C0681906
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
item	O
bank	I:C0282574
and	O
short	O
form	I:C0349674
scale	I:C0349674
.	O

Development	O
and	O
validation	O
of	O
the	O
self	B:C0681906
-	I:C0681906
reported	I:C0681906
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
item	O
bank	I:C0282574
and	O
short	O
form	I:C0349674
scale	I:C0349674
.	O

Development	O
and	O
validation	O
of	O
the	O
self	O
-	I:C0681906
reported	I:C0681906
Patient	B:C2964659
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
item	O
bank	I:C0282574
and	O
short	O
form	I:C0349674
scale	I:C0349674
.	O

Development	O
and	O
validation	O
of	O
the	O
self	O
-	I:C0681906
reported	I:C0681906
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
item	B:C0282574
bank	I:C0282574
and	O
short	O
form	I:C0349674
scale	I:C0349674
.	O

Development	O
and	O
validation	O
of	O
the	O
self	O
-	I:C0681906
reported	I:C0681906
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
item	O
bank	I:C0282574
and	O
short	B:C0349674
form	I:C0349674
scale	I:C0349674
.	O

Pain	O
behaviors	O
are	O
important	O
indicators	O
of	O
functioning	O
in	O
chronic	B:C0150055
pain	I:C0150055
;	O
however	O
,	O
no	O
self	O
-	I:C0681906
reported	I:C0681906
pain	O
behavior	O
instrument	O
has	O
been	O
developed	O
for	O
pediatric	O
populations	O
.	O

Pain	O
behaviors	O
are	O
important	O
indicators	O
of	O
functioning	O
in	O
chronic	O
pain	I:C0150055
;	O
however	O
,	O
no	O
self	B:C0681906
-	I:C0681906
reported	I:C0681906
pain	O
behavior	O
instrument	O
has	O
been	O
developed	O
for	O
pediatric	O
populations	O
.	O

Pain	O
behaviors	O
are	O
important	O
indicators	O
of	O
functioning	O
in	O
chronic	O
pain	I:C0150055
;	O
however	O
,	O
no	O
self	O
-	I:C0681906
reported	I:C0681906
pain	O
behavior	O
instrument	B:C0038951
has	O
been	O
developed	O
for	O
pediatric	O
populations	O
.	O

Pain	O
behaviors	O
are	O
important	O
indicators	O
of	O
functioning	O
in	O
chronic	O
pain	I:C0150055
;	O
however	O
,	O
no	O
self	O
-	I:C0681906
reported	I:C0681906
pain	O
behavior	O
instrument	O
has	O
been	O
developed	O
for	O
pediatric	O
populations	B:C1257890
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
create	O
a	O
brief	O
pediatric	O
measure	O
of	O
patient	B:C0681906
-	I:C0681906
reported	I:C0681906
pain	O
behaviors	O
as	O
part	O
of	O
the	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
(	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
)	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
create	O
a	O
brief	O
pediatric	O
measure	O
of	O
patient	O
-	I:C0681906
reported	I:C0681906
pain	O
behaviors	O
as	O
part	O
of	O
the	O
Patient	B:C2964659
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
(	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
)	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
create	O
a	O
brief	O
pediatric	O
measure	O
of	O
patient	O
-	I:C0681906
reported	I:C0681906
pain	O
behaviors	O
as	O
part	O
of	O
the	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
(	O
Patient	B:C2964659
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
)	O
.	O

A	O
pool	O
of	O
47	O
candidate	B:C0282574
items	I:C0282574
for	O
this	O
measure	O
had	O
been	O
previously	O
developed	O
through	O
qualitative	O
research	I:C0949415
.	O

A	O
pool	O
of	O
47	O
candidate	O
items	I:C0282574
for	O
this	O
measure	O
had	O
been	O
previously	O
developed	O
through	O
qualitative	B:C0949415
research	I:C0949415
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	B:C0150055
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	B:C3896653
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	B:C3896653
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	B:C3495559
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	B:C3495559
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	B:C0002895
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	B:C0002895
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	B:C3839701
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	B:C0282574
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	B:C0282574
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	B:C4086721
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	B:C0086132
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	B:C0015672
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	B:C3898742
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	O
catastrophizing	I:C3178745
.	O

In	O
this	O
study	O
,	O
youth	O
with	O
chronic	O
pain	I:C0150055
associated	O
with	O
juvenile	O
fibromyalgia	I:C3896653
(	O
juvenile	O
fibromyalgia	I:C3896653
)	O
,	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
(	O
juvenile	O
idiopathic	I:C3495559
arthritis	I:C3495559
)	O
,	O
or	O
sickle	O
cell	I:C0002895
disease	I:C0002895
(	O
sickle	O
cell	I:C0002895
disease	I:C0002895
)	O
(	O
ages	O
8	O
to	O
18	O
years	O
)	O
from	O
three	O
pediatric	O
centers	I:C3839701
completed	O
all	O
47	O
candidate	O
items	O
for	O
development	O
of	O
the	O
pain	O
behavior	O
item	O
bank	I:C0282574
along	O
with	O
established	O
measures	O
of	O
pain	O
interference	I:C4086721
,	O
depressive	O
symptoms	I:C0086132
,	O
fatigue	O
,	O
average	O
pain	I:C3898742
intensity	I:C3898742
,	O
and	O
pain	B:C3178745
catastrophizing	I:C3178745
.	O

Caregivers	B:C0085537
reported	O
on	O
socio-	O
demographic	O
information	O
and	O
health	O
history	I:C0455458
.	O

Caregivers	O
reported	O
on	O
socio-	O
demographic	O
information	O
and	O
health	B:C0455458
history	I:C0455458
.	O

Psychometric	B:C0033920
properties	O
of	O
the	O
pain	O
behavior	O
items	O
were	O
examined	O
using	O
an	O
item	O
response	O
theory	O
(	O
IRT	O
)	O
framework	O
with	O
confirmatory	O
factor	O
analysis	O
and	O
examination	O
of	O
differential	O
item	O
functioning	O
,	O
internal	O
consistency	O
,	O
and	O
test	O
information	I:C0282574
curves	I:C0282574
.	O

Psychometric	O
properties	O
of	O
the	O
pain	O
behavior	O
items	B:C0282574
were	O
examined	O
using	O
an	O
item	O
response	O
theory	O
(	O
IRT	O
)	O
framework	O
with	O
confirmatory	O
factor	O
analysis	O
and	O
examination	O
of	O
differential	O
item	O
functioning	O
,	O
internal	O
consistency	O
,	O
and	O
test	O
information	I:C0282574
curves	I:C0282574
.	O

Psychometric	O
properties	O
of	O
the	O
pain	O
behavior	O
items	O
were	O
examined	O
using	O
an	O
item	O
response	O
theory	O
(	O
IRT	O
)	O
framework	O
with	O
confirmatory	O
factor	O
analysis	O
and	O
examination	B:C0582103
of	O
differential	O
item	O
functioning	O
,	O
internal	O
consistency	O
,	O
and	O
test	O
information	I:C0282574
curves	I:C0282574
.	O

Psychometric	O
properties	O
of	O
the	O
pain	O
behavior	O
items	O
were	O
examined	O
using	O
an	O
item	O
response	O
theory	O
(	O
IRT	O
)	O
framework	O
with	O
confirmatory	O
factor	O
analysis	O
and	O
examination	O
of	O
differential	O
item	B:C0282574
functioning	O
,	O
internal	O
consistency	O
,	O
and	O
test	O
information	I:C0282574
curves	I:C0282574
.	O

Psychometric	O
properties	O
of	O
the	O
pain	O
behavior	O
items	O
were	O
examined	O
using	O
an	O
item	O
response	O
theory	O
(	O
IRT	O
)	O
framework	O
with	O
confirmatory	O
factor	O
analysis	O
and	O
examination	O
of	O
differential	O
item	O
functioning	O
,	O
internal	O
consistency	O
,	O
and	O
test	B:C0282574
information	I:C0282574
curves	I:C0282574
.	O

Results	O
were	O
used	O
,	O
along	O
with	O
expert	O
consensus	O
and	O
alignment	O
with	O
the	O
adult	O
Patient	B:C2964659
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pain	O
behavior	O
items	O
to	O
arrive	O
at	O
an	O
8	O
-	O
item	O
pediatric	O
pain	O
behavior	O
short	O
form	I:C0349674
,	O
and	O
all	O
47	O
items	O
were	O
retained	O
in	O
a	O
calibrated	O
item	O
bank	I:C0282574
.	O

Results	O
were	O
used	O
,	O
along	O
with	O
expert	O
consensus	O
and	O
alignment	O
with	O
the	O
adult	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pain	O
behavior	O
items	B:C0282574
to	O
arrive	O
at	O
an	O
8	O
-	O
item	O
pediatric	O
pain	O
behavior	O
short	O
form	I:C0349674
,	O
and	O
all	O
47	O
items	O
were	O
retained	O
in	O
a	O
calibrated	O
item	O
bank	I:C0282574
.	O

Results	O
were	O
used	O
,	O
along	O
with	O
expert	O
consensus	O
and	O
alignment	O
with	O
the	O
adult	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pain	O
behavior	O
items	O
to	O
arrive	O
at	O
an	O
8	O
-	O
item	B:C0282574
pediatric	O
pain	O
behavior	O
short	O
form	I:C0349674
,	O
and	O
all	O
47	O
items	O
were	O
retained	O
in	O
a	O
calibrated	O
item	O
bank	I:C0282574
.	O

Results	O
were	O
used	O
,	O
along	O
with	O
expert	O
consensus	O
and	O
alignment	O
with	O
the	O
adult	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pain	O
behavior	O
items	O
to	O
arrive	O
at	O
an	O
8	O
-	O
item	O
pediatric	O
pain	O
behavior	O
short	B:C0349674
form	I:C0349674
,	O
and	O
all	O
47	O
items	O
were	O
retained	O
in	O
a	O
calibrated	O
item	O
bank	I:C0282574
.	O

Results	O
were	O
used	O
,	O
along	O
with	O
expert	O
consensus	O
and	O
alignment	O
with	O
the	O
adult	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pain	O
behavior	O
items	O
to	O
arrive	O
at	O
an	O
8	O
-	O
item	O
pediatric	O
pain	O
behavior	O
short	O
form	I:C0349674
,	O
and	O
all	O
47	O
items	B:C0282574
were	O
retained	O
in	O
a	O
calibrated	O
item	O
bank	I:C0282574
.	O

Results	O
were	O
used	O
,	O
along	O
with	O
expert	O
consensus	O
and	O
alignment	O
with	O
the	O
adult	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pain	O
behavior	O
items	O
to	O
arrive	O
at	O
an	O
8	O
-	O
item	O
pediatric	O
pain	O
behavior	O
short	O
form	I:C0349674
,	O
and	O
all	O
47	O
items	O
were	O
retained	O
in	O
a	O
calibrated	O
item	B:C0282574
bank	I:C0282574
.	O

Confirmatory	O
factor	O
analysis	O
and	O
correlations	O
with	O
validated	O
measures	O
of	O
pain	B:C0030193
,	O
pain	O
interference	I:C4086721
,	O
and	O
psychosocial	O
functioning	O
provided	O
support	O
for	O
the	O
short	O
form	I:C0349674
's	I:C0349674
reliability	O
and	O
validity	O
.	O

Confirmatory	O
factor	O
analysis	O
and	O
correlations	O
with	O
validated	O
measures	O
of	O
pain	O
,	O
pain	B:C4086721
interference	I:C4086721
,	O
and	O
psychosocial	O
functioning	O
provided	O
support	O
for	O
the	O
short	O
form	I:C0349674
's	I:C0349674
reliability	O
and	O
validity	O
.	O

Confirmatory	O
factor	O
analysis	O
and	O
correlations	O
with	O
validated	O
measures	O
of	O
pain	O
,	O
pain	O
interference	I:C4086721
,	O
and	O
psychosocial	O
functioning	O
provided	O
support	O
for	O
the	O
short	B:C0349674
form	I:C0349674
's	I:C0349674
reliability	O
and	O
validity	O
.	O

The	O
new	O
Patient	B:C2964659
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
scale	O
provides	O
a	O
reliable	O
,	O
precise	O
,	O
and	O
valid	O
measure	O
for	O
future	O
research	O
on	O
pain	O
behavior	O
in	O
school	O
-	O
age	O
children	O
with	O
chronic	O
pain	I:C0150055
.	O

The	O
new	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
scale	B:C0349674
provides	O
a	O
reliable	O
,	O
precise	O
,	O
and	O
valid	O
measure	O
for	O
future	O
research	O
on	O
pain	O
behavior	O
in	O
school	O
-	O
age	O
children	O
with	O
chronic	O
pain	I:C0150055
.	O

The	O
new	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
scale	O
provides	O
a	O
reliable	O
,	O
precise	O
,	O
and	O
valid	O
measure	O
for	O
future	O
research	B:C0035168
on	O
pain	O
behavior	O
in	O
school	O
-	O
age	O
children	O
with	O
chronic	O
pain	I:C0150055
.	O

The	O
new	O
Patient	O
-	I:C2964659
Reported	I:C2964659
Outcome	I:C2964659
Measurement	I:C2964659
Information	I:C2964659
System	I:C2964659
pediatric	O
pain	O
behavior	O
scale	O
provides	O
a	O
reliable	O
,	O
precise	O
,	O
and	O
valid	O
measure	O
for	O
future	O
research	O
on	O
pain	O
behavior	O
in	O
school	O
-	O
age	O
children	O
with	O
chronic	B:C0150055
pain	I:C0150055
.	O

